Morinda, Inc.

Tahitian Noni International, Inc.

Afa Kehaati Palu

Claude Jarakae Jensen

Stephen P Story

Brett Justin West

Chen Su

Bing-Nan Zhou

Robert Ogden

Shixin Deng

Scott Gerson

Hisanori Tani

Hifumi Ohishi

Claude Jarake Jensen

C Jarakae Jensen

Richard G Godbee

John W Wadsworth

Summer Jensen

Mian Ying Wang

Johannes Joseph Westendorf

Jeffrey A Wasden

Shixin Dong

Jeffery A Wasden

Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced withand iridoids.

[object Object]

Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an ICof 3.8 &#x3bc;L/mL. In vivo bioactivities were evaluated in type 2 diabetic Sprague Dawley rats. In a dose-dependent manner, the composition reduced abnormal weight gain, blood glucose levels, and serum advanced glycation end products (AGEs), as well as improved immunity via increased T cell counts and CD4+/CD8ratios.

The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processedbased formulations.

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processedproduct that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processedproducts for a safe, pre-determined duration.

Selectively inhibiting estrogen production and providing estrogenic effects in the human body

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.

The present invention features a formulation from the Indian mulberry plant () comprisingfruit juice,oil, quercetin,puree juice anddietary fiber treating Candidiasis.

Methods and compositions relating to leaf extracts obtained fromleaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from theL. plant. Methods and compositions relating to leaf extract compositions comprising one or more of the leaf extracts and leaf serums.

The present invention advances prior art animal food products by providing an animal food product formulated with., or Mangosteen fruit, from the Mangosteen plant. The addition of Mangosteen to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.

The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processedproducts as derived from the Indian Mulberry plant. Theis particularly adapted to treat Type II diabetes. Theproduct is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processedproduct or an active ingredient there from, as obtained from the Indian Mulberry plant.

Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor

The present invention relates to antifungal and antibacterial activity of processedproducts, as well as from various fractions of extracts from these processed products and the. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.

Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice

The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as

The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed-based naturaceutical formulations comprising one or more of a processedfruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth offungus and for treating Candidiasis and its associated symptoms.

Growing community of inventors

Orem, UT, United States of America

Afa Kehaati Palu